Literature DB >> 18512757

Predictors and course of health-related quality of life in Parkinson's disease.

Elin Bjelland Forsaa1, Jan Petter Larsen, Tore Wentzel-Larsen, Karen Herlofson, Guido Alves.   

Abstract

We investigated how health related quality of life (HRQL) changes over time in a population-based cohort of patients with Parkinson's disease (PD), and which factors predict a lower level of HRQL in these patients. Of 227 patients with PD assessed at baseline and followed prospectively, information on HRQL-status was obtained in 111 subjects 4 years and 82 patients 8 years after inclusion. HRQL was measured by the Nottingham Health Profile (NHP). Analyses were conducted using generalized estimating equation models. The NHP total score (P < 0.001) and scores in all NHP dimensions except for sleep worsened significantly during follow-up. Steepest slope was found for the domain physical mobility (3.16, 95% CI 2.39-3.92), followed by the domains social isolation (2.22, 95% CI 1.52-2.93) and emotional reactions (1.36, 95% CI 0.74-1.97). In addition to follow-up time, higher Hoehn and Yahr staging, higher Montgomery and Aasberg Depression Rating Scale scores, and presence of insomnia at baseline were associated with lower levels of overall HRQL during follow-up. We conclude that PD has an increasing impact on HRQL as the disease progresses. During long-term follow-up, deterioration in physical mobility was the most important single factor contributing to decline in HRQL in our cohort, although distress of nonmotor character as a whole outweighed the impact of distress in physical mobility on overall HRQL. More advanced disease, higher severity of depressive symptoms, and presence of insomnia were found to be important and independent predictors of poor HRQL. (c) 2008 Movement Disorder Society.

Entities:  

Mesh:

Year:  2008        PMID: 18512757     DOI: 10.1002/mds.22121

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  63 in total

1.  A meta-regression of the long-term effects of deep brain stimulation on balance and gait in PD.

Authors:  R J St George; J G Nutt; K J Burchiel; F B Horak
Journal:  Neurology       Date:  2010-10-05       Impact factor: 9.910

2.  Predictors of treatment response to cognitive-behavioral therapy for depression in Parkinson's disease.

Authors:  Roseanne D Dobkin; Jade Tiu Rubino; Lesley A Allen; Jill Friedman; Michael A Gara; Margery H Mark; Matthew Menza
Journal:  J Consult Clin Psychol       Date:  2012-03-12

3.  Health-related quality of life in Parkinson's: impact of 'off' time and stated treatment preferences.

Authors:  Cicely Kerr; Emily J Lloyd; Charlotte E Kosmas; Helen T Smith; James A Cooper; Karissa Johnston; Emma McIntosh; Andrew J Lloyd
Journal:  Qual Life Res       Date:  2015-12-01       Impact factor: 4.147

4.  Change in Cognition and Other Non-Motor Symptoms With Obstructive Sleep Apnea Treatment in Parkinson Disease.

Authors:  Marta Kaminska; Victoria P Mery; Anne-Louise Lafontaine; Ann Robinson; Andrea Benedetti; Priti Gros; R John Kimoff
Journal:  J Clin Sleep Med       Date:  2018-05-15       Impact factor: 4.062

Review 5.  Safety and Tolerability of Pharmacotherapies for Parkinson's Disease in Geriatric Patients.

Authors:  Martin Klietz; Stephan Greten; Florian Wegner; Günter U Höglinger
Journal:  Drugs Aging       Date:  2019-06       Impact factor: 3.923

6.  A 5-year prospective assessment of advanced Parkinson disease patients treated with subcutaneous apomorphine infusion or deep brain stimulation.

Authors:  Angelo Antonini; Ioannis U Isaias; Giorgia Rodolfi; Andrea Landi; Francesca Natuzzi; Chiara Siri; Gianni Pezzoli
Journal:  J Neurol       Date:  2010-10-23       Impact factor: 4.849

7.  Neuropsychological outcomes after psychosocial intervention for depression in Parkinson's disease.

Authors:  Roseanne D Dobkin; Alexander I Tröster; Jade Tiu Rubino; Lesley A Allen; Michael A Gara; Margery H Mark; Matthew Menza
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2014       Impact factor: 2.198

8.  Parkinson's disease: how is employment affected?

Authors:  R Murphy; N Tubridy; H Kevelighan; S O'Riordan
Journal:  Ir J Med Sci       Date:  2013-01-17       Impact factor: 1.568

9.  Gait function and locus coeruleus Lewy body pathology in 51 Parkinson's disease patients.

Authors:  Kelly A Mills; Zoltan Mari; Catherine Bakker; Vanessa Johnson; Gregory M Pontone; Alexander Pantelyat; Juan C Troncoso; Olga Pletnikova; Ted M Dawson; Liana S Rosenthal
Journal:  Parkinsonism Relat Disord       Date:  2016-09-25       Impact factor: 4.891

10.  Barriers to mental health care utilization in Parkinson's disease.

Authors:  Roseanne D Dobkin; Jade Tiu Rubino; Jill Friedman; Lesley A Allen; Michael A Gara; Matthew Menza
Journal:  J Geriatr Psychiatry Neurol       Date:  2013-04-15       Impact factor: 2.680

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.